SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-462479"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-462479" > Outcomes of COVID-1...

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry : a retrospective cohort study

Sattui, Sebastian E. (författare)
Hosp Special Surg, Dept Med, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA.;Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA.
Conway, Richard (författare)
St James Hosp, Dept Rheumatol, Dublin D08 NHY1, Ireland.
Putman, Michael S. (författare)
Med Coll Wisconsin, Milwaukee, WI 53226 USA.
visa fler...
Seet, Andrea M. (författare)
Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.
Gianfrancesco, Milena A. (författare)
Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.
Beins, Kaley (författare)
Vasculitis Fdn, Kansas City, MO USA.
Hill, Catherine (författare)
Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA, Australia.;Univ Adelaide, Discipline Med, Adelaide, SA, Australia.
Liew, David (författare)
Austin Hlth, Dept Rheumatol, Melbourne, Vic, Australia.;Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
Mackie, Sarah L. (författare)
Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.;Leeds Teaching Hosp NHS Trust, Leeds Biomed Res Ctr, Leeds, W Yorkshire, England.
Mehta, Puja (författare)
UCL, Ctr Inflammat & Tissue Repair, UCL Resp, London, England.;Univ Coll London Hosp NHS Fdn Trust, Dept Rheumatol, London, England.
Neill, Lorna (författare)
Polymyalgia Rheumat & Giant Cell Arteritis Scotla, Perth, Scotland.
Gomez, Gimena (författare)
Argentine Soc Rheumatol, Res Unit, Buenos Aires, DF, Argentina.
Salinas, Maria Isabel Haye (författare)
Univ Nacl la Rioja, Reumatologa CEMMA, La Rioja, Argentina.
Maldonado, Federico Nicolas (författare)
Sanatorio Guemes Hosp Privado, Buenos Aires, DF, Argentina.
Mariz, Henrique Ataide (författare)
Univ Fed Pernanmbuco, Hosp Clin, Pernanmbuco, Brazil.
Studart, Samia Araujo de Sousa (författare)
Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil.
Araujo, Nafice Costa (författare)
Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil.
Knight, Ann (författare)
Uppsala universitet,Reumatologi
Rozza, Davide (författare)
Italian Soc Rheumatol, Epidemiol Res Unit, Milan, Italy.
Quartuccio, Luca (författare)
Univ Udine, Santa Maria della Misericordia Acad Hosp, Sch Rheumatol, Dept Med,Clin Rheumatol, Udine, Italy.
Samson, Maxime (författare)
Dijon Univ Hosp, Dept Internal Med & Clin Immunol, Dijon, France.
Bally, Stephane (författare)
Metropole Savoie Hosp Ctr, Nephrol & Dialysis Serv, Chambery, France.
Maria, Alexandre T. J. (författare)
St Eloi Univ Hosp Montpellier, Dept Internal Med & Multiorgan Dis, Montpellier, France.
Chazerain, Pascal (författare)
Diaconesses Croix St Simon Hosp, Dept Rheumatol & Internal Med, Paris, France.
Hasseli, Rebecca (författare)
Justus Liebig Univ Giessen, Dept Rheumatol & Clin Immunol, Campus Kerckhoff, Bad Nauheim, Germany.
Muller-Ladner, Ulf (författare)
Justus Liebig Univ Giessen, Dept Rheumatol & Clin Immunol, Campus Kerckhoff, Bad Nauheim, Germany.
Hoyer, Bimba F. (författare)
Univ Hosp Schleswig Holstein, Dept Rheumatol & Clin Immunol, Clin Internal Med 1, Kiel, Germany.
Voll, Reinhard (författare)
Albert Ludwigs Univ Freiburg, Univ Med Ctr, Fac Med, Dept Rheumatol & Clin Immunol, Freiburg, Germany.
Torres, Rita Pinheiro (författare)
Nova Med Sch, CEDOC, Lisbon, Portugal.;Egas Moniz Hosp, Lisboa Occidental Hosp Ctr, Rheumatol Serv, Lisbon, Portugal.
Luis, Mariana (författare)
Ctr Hosp & Univ Coimbra, Dept Rheumatol, Coimbra, Portugal.;Univ Coimbra, Sch Med, Coimbra, Portugal.
Ribeirio, Sandra Lucia Euzebio (författare)
Univ Fed Amazonas, Manaus, Amazonas, Brazil.
Al-Emadi, Samar (författare)
Hamad Med Corp, Doha, Qatar.
Sparks, Jeffrey A. (författare)
Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.
Hsu, Tiffany Y-T (författare)
Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.
D'Silva, Kristin M. (författare)
Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.
Patel, Naomi J. (författare)
Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.
Wise, Leanna (författare)
Los Angeles Cty Hosp, Los Angeles, CA USA.;Univ South Calif, Med Ctr, Los Angeles, CA 90007 USA.
Gilbert, Emily (författare)
Mayo Clin Hlth Syst, Div Rheumatol, Jacksonville, FL USA.
Almada, Maria Valenzuela (författare)
Mayo Clin Hlth Syst, Div Rheumatol, Rochester, MN USA.
Duarte-Garcia, Ali (författare)
Mayo Clin Hlth Syst, Div Rheumatol, Rochester, MN USA.
Ugarte-Gil, Manuel (författare)
Univ Cient Sur, Sch Med, Lima, Peru.;EsSalud, Rheumatol Dept, Hosp Guillermo Almenara Irigoyen, Lima, Peru.
Jacobsohn, Lindsay (författare)
Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.
Izadi, Zara (författare)
Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.
Strangfeld, Anja (författare)
German Rheumatism Res Ctr, Epidemiol & Hlth Care Res, Berlin, Germany.
Mateus, Elsa F. (författare)
Portuguese League Rheumat Dis, Lisbon, Portugal.
Hyrich, Kimme L. (författare)
Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England.;Univ Manchester, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.;Manchester Univ NHS Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.
Gossec, Laure (författare)
Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France.;Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Rheumatol, Paris, France.
Carmona, Loreto (författare)
Inst Salud Musculoesquelet, Madrid, Spain.
Lawson-Tovey, Saskia (författare)
Univ Manchester, Ctr Musculoskeletal Res, Ctr Genet & Gen Versus Arthrit, Manchester, Lancs, England.;Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
Kearsley-Fleet, Lianne (författare)
Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England.
Schaefer, Martin (författare)
German Rheumatism Res Ctr, Epidemiol & Hlth Care Res, Berlin, Germany.
Sirotich, Emily (författare)
McMaster Univ, Hamilton, ON, Canada.;Canadian Arthrit Patient Alliance, Toronto, ON, Canada.
Hausmann, Jonathan S. (författare)
Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.;Boston Childrens Hosp, Boston, MA USA.
Sufka, Paul (författare)
HealthPartners, St Paul, MN USA.
Bhana, Suleman (författare)
Crystal Run Hlth, Middletown, NY USA.
Liew, Jean W. (författare)
Boston Univ, Sch Med, Boston, MA 02118 USA.
Grainger, Rebecca (författare)
Univ Otago, Wellington, New Zealand.
Machado, Pedro M. (författare)
UCL, Ctr Rheumatol, London, England.;UCL, Dept Neuromuscular Dis, London, England.;Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England.;London North West Univ Healthcare NHS Trust, Northwick Pk Hosp, Dept Rheumatol, London, England.
Wallace, Zachary S. (författare)
Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.
Yazdany, Jinoos (författare)
Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.
Robinson, Philip C. (författare)
Univ Queensland, Brisbane, Qld, Australia.;Royal Brisbane & Womens Hosp, Metro North Hosp & Hlth Serv, Herston, Qld, Australia.
visa färre...
Hosp Special Surg, Dept Med, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA;Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA. St James Hosp, Dept Rheumatol, Dublin D08 NHY1, Ireland. (creator_code:org_t)
Elsevier, 2021
2021
Engelska.
Ingår i: LANCET RHEUMATOLOGY. - : Elsevier. - 2665-9913. ; 3:12, s. E855-E864
Relaterad länk:
https://urn.kb.se/re...
visa fler...
https://doi.org/10.1...
visa färre...
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We therefore aimed to investigate factors associated with COVID-19 outcomes in patients with primary systemic vasculitis or polymyalgia rheumatica. Methods In this retrospective cohort study, adult patients (aged >= 18 years) diagnosed with COVID-19 between March 12, 2020, and April 12, 2021, who had a history of primary systemic vasculitis (antineutrophil cytoplasmic antibody [ANCA]-associated vasculitis, giant cell arteritis, Behcet's syndrome, or other vasculitis) or polymyalgia rheumatica, and were reported to the COVID-19 Global Rheumatology Alliance registry were included. To assess COVID-19 outcomes in patients, we used an ordinal COVID-19 severity scale, defined as: (1) no hospitalisation; (2) hospitalisation without supplemental oxygen; (3) hospitalisation with any supplemental oxygen or ventilation; or (4) death. Multivariable ordinal logistic regression analyses were used to estimate odds ratios (ORs), adjusting for age, sex, time period, number of comorbidities, smoking status, obesity, glucocorticoid use, disease activity, region, and medication category. Analyses were also stratified by type of rheumatic disease. Findings Of 1202 eligible patients identified in the registry, 733 (61.0%) were women arid 469 (39.0%) were men, and their mean age was 63.8 years (SD 17.1). A total of 374 (31.1%) patients had polymyalgia rheumatica, 353 (29.4%) had ANCA-associated vasculitis, 183 (15.2%) had giant cell arteritis, 112 (9.3%) had Behcet's syndrome, and 180 (15.0%) had other vasculitis. Of 1020 (84. 9%) patients with outcome data, 512 (S0.2%) were not hospitalised, 114 (11.2%) were hospitalised and did not receive supplemental oxygen, 239 (23 - 4%) were hospitalised and received ventilation or supplemental oxygen, and 155 (15.2%) died. A higher odds of poor COVID-19 outcomes were observed in patients who were older (per each additional decade of life OR 1.44 [95% CI 1. 31-1- 571), were male compared with female (1.38 [1.05-1.801), had more comorbidities (per each additional comorbidity 1.39 [1- 23-1- 581), were taking 10 mg/day or more of prednisolone compared with none (2.14 [1.50-3.04J), or had moderate, or high or severe disease activity compared with those who had disease remission or low disease activity (2.12 [1.49-3.021). Risk factors varied among different disease subtypes. Interpretation Among patients with primary systemic vasculitis and polymyalgia rheumatica, severe COVID-19 outcomes were associated with variable and largely unmodifiable risk factors, such as age, sex, and number of comorbidities, as well as treatments, including high-dose glucocorticoids. Our results could be used to info rm mitigation strategies for patients with these diseases. 

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy